HB 345 modifies Utah's victim reparations law to expand access for specific victims. It specifically allows mental health counseling as part of reparations for individuals who experienced sexual assault while incarcerated in a prison, jail, or correctional facility. The bill also updates the legal definition of "criminally injurious conduct" and makes technical changes to existing code sections (63M-7-502, 63M-7-509, and 63M-7-510). These changes directly affect incarcerated sexual assault victims seeking reparations for psychological harm. The bill does not appropriate new funds.
HB 156 allows patients to use their own blood or blood from a designated donor (like a family member) for transfusions, unless it's an emergency, there's insufficient time to arrange it, or the healthcare facility already has a process for patient-provided blood. It prohibits healthcare facilities from blocking this option and provides liability protection for providers if injuries occur from using such blood, unless the provider was grossly negligent. The bill directly affects patients needing transfusions and Utah healthcare facilities, taking effect in May 2026. It defines key terms and aligns with federal blood collection laws, with no funding impact.
HB 442 requires manufacturers of menstrual products sold in Utah to list specific chemicals (like lead, cadmium, arsenic, and PFAS) and intentionally added ingredients on product packaging. It directly affects manufacturers of tampons, sanitary napkins, menstrual cups, and similar products sold in the state. The Division of Consumer Protection will enforce these labeling rules and create related regulations. This bill increases transparency about ingredients in feminine hygiene products without changing product safety standards or requiring new funding.
HB 14 extends the expiration date for Utah's Behavior Analyst Licensing Act from July 1, 2026, to July 1, 2036. This change ensures the law governing behavior analyst licensure remains in effect for an additional decade, preventing its automatic repeal. The bill includes minor technical adjustments to the relevant code but does not alter licensing requirements for behavior analysts. This extension directly affects behavior analysts and the state's regulatory process for their professional licensing.
HB 28 extends the expiration dates for several health-related programs and committees under Utah's Department of Health and Human Services. It specifically delays the sunset (repeal) of programs like the Rare Disease Advisory Council Grant Program, Newborn Hearing Screening Committee, Mobile Crisis Outreach Team Grant Program, and Behavioral Health Receiving Center Grant Program, pushing their expiration dates from 2026 to 2036 or later. The bill amends Utah Code sections to adjust these repeal deadlines without creating new programs or appropriating funds. These changes directly affect the ongoing operation of these advisory bodies and grant initiatives, allowing them to continue functioning past their original expiration dates.
HB 70 requires Utah's Department of Health and Human Services to implement a new electronic health record system for inmate care by 2026, based on a working group's recommendations. It makes funds for unexpected high-cost correctional health care non-lapsing (meaning they won't expire if unused), and mandates a treatment plan for all inmates with substance use disorders, including medication-based treatment. The bill also sets accreditation standards for correctional health facilities and allows parole boards to consider health examiner reports when deciding parole conditions. These changes directly affect inmates in Utah's correctional facilities, the Department of Health and Human Services, and the Department of Corrections.
HB 356 clarifies Utah's rules for the federal 340B drug discount program, which provides discounted medications to eligible healthcare organizations. It defines key terms like "340B covered entity" (e.g., hospitals or clinics participating in the federal program) and prohibits drug manufacturers from restricting contracts between pharmacies and these entities or requiring excessive data sharing beyond federal requirements. The bill directly affects 340B-covered entities, pharmacies, and drug manufacturers by ensuring they cannot interfere with program participation or impose unnecessary conditions. It makes technical updates to Utah law without new funding, aligning state rules with federal program standards.
HB 7 is the Social Services Base Budget for Utah’s fiscal years 2026 and 2027, providing $8.6 billion in total funding to state agencies, primarily the Department of Health and Human Services. It directly affects programs like Child and Family Services, Medicaid, mental health services, and health care administration by allocating specific funds - such as $1.588 billion from the General Fund for 2027 and $53.38 million for legal cost reporting. Key provisions include requiring the Health and Human Services Department to report to lawmakers by May 2026 on attorney fees for child welfare services, including historical costs and funding gaps. The bill establishes concrete budget allocations for operations, capital projects, and specific initiatives without changing program eligibility or creating new requirements.
